Home
Conditions
Biliary Tract Neoplasms

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

50 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Completed

LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent

NCT04595058

Conditions: Biliary Obstruction, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
Locations: Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain

Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain

View Trial Details

Completed

TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer

NCT05190575

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations: Zhongshan hospital Shanghai, China

View Trial Details

Completed

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

NCT02821754

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy

NCT02784353

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +10 more
Locations: Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

NCT03101566

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations: Emory University Atlanta, Georgia, United States

Northwestern University Chicago, Illinois, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

NCT03111732

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

NCT03504293

Conditions: Biliary Stricture, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Completed

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

NCT01853618

Conditions: Adenocarcinoma, Biliary Cancer, Biliary Tract Diseases, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer

NCT02558959

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations: First affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer

NCT01242605

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations: Hammersmith Hospital London, United Kingdom

University College London Hospital London, United Kingdom

The Christie Hospital Manchester, United Kingdom

View Trial Details

Biliary Tract Neoplasms

Biliary Tract Neoplasms trial results

Related conditions